March 2025 – content

Life Sciences

Standex snaps up freezer specialist for quarter of its annual revenues

Cube Biotech buys protein tag firm IBA Lifesciences

Acquisition to lead Quanterix to profitability

London-based DNA manufacturing firm expands customer base

Bio-Rad acquires multiplexing dPCR company Stilla

Takara Bio buys transcriptome spatial mapping company

General Laboratory

Equity-backed AAT makes two more European purchases

Agilent creates separate applied markets segment

JEOL and Kobe Steel buy superconducting wire firm

Restructuring, rightsizing and acquisition at SDI

Antylia to be auctioned off by equity investment owners

Process & hand-held instrumentation

Savillex buys bioprocessing and containment companies

Emerson to sell Safety & Productivity business

IRUBIS raises pre-series A funding              

Industrial Physics makes two acquisitions under new owner

DwyerOmega acquires PST in deal between equity companies

SepPure starts trial scheme                            

Features

TDA Instrument Industry Outlook for 2025:

Glimmers of hope after three years of decline

Financials

NGS and synthetic gene markets push Twist to record results

Neogen feels food price inflation

Standex Scientic mainly grows on purchase

Biopharma headwinds prevent Bio-Rad growth in 2024

Laboratory division flatlines organically at Porvair

AddLife Labtech buoyed by organic growth and acquisition

IQR back to single digit growth at Zeiss' full fiscal year

Nikon sees a delay of life science recovery

Semicon production and analytical instruments buoy JEOL in first fiscal half

Restructured SDI relies on acquisition to hold decline at bay              

Chinese weakness stymies Ingersoll Rand

Currency headwinds cancel out acquired revenues at OI

Good quarterly growth at Waters hints at 2025 recovery

Industrial businesses continue to decline at Parker Hannifin

Varex sees ongoing destocking and weak China business

Filtration sales grow organically at Solventum

Donaldson reduces long-term forecast on slowing biopharma market

Growth down for Emerson’s measurement and analytical businesses

Appointments